Basophil Activation Test (BAT) Sensitivity in Child Food Allergy
TAB-TPO
1 other identifier
interventional
140
1 country
1
Brief Summary
Child food allergy represent 6 to 8% of child in industrialised country. Within this allergy, peanuts and egg allergy are one of the most common. Actually when there is a suspicion of food allergy, the OPT is the gold standard for the diagnosis. During the OPT we give increasing doses of the allergen to the patient and evaluate threshold causing a clinical reaction. This test is associated with a risk of strong allergic reaction and need a medical supervision. Standard allergy test, like skin test or specific IgE test, can't be use for the diagnosis of these allergy. Some publications demonstrate that these tests lack sensibility and specificity for child food allergy diagnosis. New tests have to be develop to diagnosis child food allergy without risks. The BAT is a cellular test able to evaluate the basophiles activation by specific allergen in vitro. This test allow us to evaluate more physiologically the sensitization of patients to an allergen. It is already used in drug allergy and it has been evaluated in infant milk allergy in an other clinical trial. In this study we want to evaluate the sensitivity of BAT to the diagnosis of child food allergy compare to the gold standard test OPT. We will evaluate the BAT on 140 children with food allergy and compare this results with the OPT at the same time. If the BAT results can predict the sensitivity of children to food allergen, it could limit the use of the OPT and reduce the risk of this test.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Sep 2013
Longer than P75 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 12, 2013
CompletedFirst Submitted
Initial submission to the registry
October 11, 2013
CompletedFirst Posted
Study publicly available on registry
October 21, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 11, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 11, 2019
CompletedApril 16, 2026
April 1, 2026
5.3 years
October 11, 2013
April 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sensitivity of the Basophil Activation Test
Sensitivity of the BAT compare to OPT with a threshold value of 6% for the BAT in a population of child food allergy. Sensitivity is defined as the capacity for BAT to have a positive result when OAT result is also positive (diagnosis of allergy confirmed)
Day 1
Secondary Outcomes (1)
Evaluation of the proportion of child positive to the BAT
Day 1
Study Arms (1)
Child food allergy suspicion
EXPERIMENTALBasophil Activation Test realized in case of Child food egg and peanut allergy suspicion
Interventions
blood sample for Basophil Activation Test
Eligibility Criteria
You may qualify if:
- Child older than 6 months and less than 18 years old
- Diagnosis of type I allergy to peanut or egg
- oral provocation test to peanut or egg programmed
You may not qualify if:
- No possibility to assess blood sample
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UH Rouen
Rouen, 76031, France
Related Publications (1)
Carrette M, Couderc L, Bubenheim M, Vidal A, Youssouf A, Boyer O, Marguet C, Martinet J. The combination of Ara h 2-sIgE and basophil activation test could be an alternative to oral food challenge in cases of suspected peanut allergy. Pediatr Allergy Immunol. 2023 Aug;34(8):e14007. doi: 10.1111/pai.14007.
PMID: 37622254RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laure COUDERC, Dr
UH Rouen
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 11, 2013
First Posted
October 21, 2013
Study Start
September 12, 2013
Primary Completion
January 11, 2019
Study Completion
January 11, 2019
Last Updated
April 16, 2026
Record last verified: 2026-04